1. Stocks
  2. Dr. Reddy's Laboratories Ltd.
  3. Swot
swot-logo

Dr. Reddy's Laboratories Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Dr. Reddy's Laboratories Ltd. has 13 Strengths, 5 Weaknesses, 3 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV

Upcoming results with Rising Delivery Volumes

Relative Outperformance versus Industry over 1 Week

Companies with Low Debt

Increasing Revenue every Quarter for the past 4 Quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Decrease in Provision in recent results

Top Gainers

Companies with growing costs YoY for long term projects

Companies that Declared Results in Past One Week, Showing Declining Net Profit YoY OR QoQ (subscription)

PEG greater than Industry PEG

Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Low Piotroski Score : Companies with weak financials

Highest FII stock holdings

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Red Flags: Firms linked to ongoing regulatory investigations/legal cases

Broker downgrades in price or recommendation in the past one month

US FDA Warning Letter

Stocks with improving cash flow, with good durability

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)